Sumitomo Dainippon Pharma Aktie
| 9,30EUR | -0,15EUR | -1,59% | 
WKN: 858257 / ISIN: JP3495000006
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 6 822 | 6 987 | 6 250 | 4 980 | 3 832 | 
| Umsatz pro Mitarbeiter in Mio. EUR | 75,63 | 80,15 | 88,89 | 63,16 | 104,08 | 
Bilanz (in Mio. JPY) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 459 795 | 499 521 | 381 860 | 269 569 | 253 168 | 
| Summe Anlagevermögen | 848 332 | 808 486 | 752 882 | 637 937 | 489 436 | 
| Summe Aktiva | 1 308 127 | 1 308 007 | 1 134 742 | 907 506 | 742 604 | 
Bilanz (in Mio. JPY) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 659 949 | 634 438 | 727 960 | 751 370 | 573 125 | 
| Summe Eigenkapital | 648 178 | 673 569 | 406 782 | 156 136 | 169 479 | 
| Summe Passiva | 1 308 127 | 1 308 007 | 1 134 742 | 907 506 | 742 604 | 
Adresse
| 2-6-8 Dosho-machi, 541-0045 Osaka | |
| Telefon | +81 (6) 6203-5321 | 
| Fax | +81 (6) 6202-6028 | 
| Internet | http://www.ds-pharma.co.jp/ | 
Management
| Hiroshi Niinuma Non-Executive Director | 
| Hiroyuki Baba Managing Executive Officer & Head-Legal Affairs | 
| Hisayoshi Kashima Director | 
| Isao Shimizu Executive Officer & Senior Research Director | 
| Kazuo Koshiya Managing Executive Officer | 
| Kenji Ueno Executive Officer & GM-Technology Research | 
| Koji Fujimoto Outside Director | 
| Mayumi Mochizuki Independent Outside Director | 
| Minoru Usui Outside Director | 
| Motoyuki Sakai Representative Director & VP-Governance | 
| Nobuhiro Endo Independent Outside Director | 
| Saeko Arai Independent Outside Director | 
| Shigeyuki Nishinaka Managing Executive Officer | 
| Taishiro Michimori Independent Outside Director | 
| Takashi Kutsunai Auditor | 
| Takuya Taguchi Managing Executive Officer & General Manager-Sales | 
| Toru Kimura President, CEO & Representative Director | 
| Tsutomu Nakagawa Director & Managing Executive Officer | 
| Yoshiharu Ikeda Head-Research & Technology | 
| Yoshinori Ooe Auditor | 
| Yoshio Iteya Independent Outside Director | 
| Yutaka Wakemi Executive Officer, VP & Head-Global Strategy | 
 
									 
									 
								